The image shows one form of CINDU, cold urticaria, in a patient who had been swimming in cold water. Novartis is on course to expand the label for its recently approved oral BTK inhibitor Rhapsido, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results